Oxford Optronix has launched its third generation OxyLite Pro and OxyFlo Pro systems for tissue oxygenation and blood flow monitoring.
Using the fibre-optic micro-sensors, OxyLite and OxyFlo systems provide real-time measurements of local tissue oxygenation (ptiO2), tissue blood perfusion (blood flow) and tissue temperature.
Designed to be used individually or for simultaneous measurements of tissue oxygenation, blood flow and temperature, the OxyLite and OxyFlo systems are used for hypoxia and ischaemia conditions.
University of Toronto's Hospital for Sick Children medical biophysics and medical imaging assistant professor Dr Hai-Ling Margaret Cheng said that OxyLite and OxyFlo allow in monitoring the tissue pO2 and perfusion response simultaneously in the liver and kidney.
"No other minimally invasive system could capture dynamic changes with such fine temporal resolution, and no other system could provide concurrent pO2 and perfusion measurement in multiple tissue regions," Cheng added.
Oxford Optronix CEO Andy Obeid said that the release of its new OxyLite Pro and OxyFlo Pro systems is the culmination of five years of continued product development.
"The introduction of our third-generation platform enables us to continue providing the 'gold-standard' in tissue vitality monitoring that our customers have come to expect," Obeid added.
Image: The OxyLite Pro and OxyFlo Pro systems. Photo: Courtesy of NeonDrum / Oxford Optronix.
